Search the Newsreel

DTIL|Precision BioSciences Inc|Price:6.990|Chg%:-0.010

This article provides a comprehensive stock analysis of Precision BioSciences Inc (DTIL), highlighting its strong fundamentals, high growth potential, and "Strong Buy" analyst rating. Despite recent weak stock market performance, the company is developing gene editing therapies using its proprietary ARCUS platform and is …

Form 144 CoreCivic For: 31 July By Investing.com

The article "Form 144 CoreCivic For: 31 July By Investing.com" is a brief notice from Investing.com confirming the filing of a Form 144 for CoreCivic (CXW) on July 31st. It provides no further details about the Form 144 itself, only listing the company name …

Wheaton Precious Metals Falls as Investors Appear to Brace for Weaker Metals Sentiment and Upcoming Earnings

Wheaton Precious Metals (WPM) saw a 3.8% decline, likely due to broader sector pressure and investor positioning ahead of its Q2 2026 earnings release on August 6. The company's stock is highly sensitive to gold and silver prices, and recent analyst target reductions amid …

Precision Optics Corporation, Inc. Revenue Breakdown – NASDAQ:POCI

Precision Optics Corporation, Inc. (NASDAQ: POCI) generated the majority of its revenue from the United States, contributing $19.09 million USD last year and $19.10 million USD the year prior. This data highlights the company's primary market for its revenue streams. The information is provided …

Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026

Precision BioSciences, Inc. announced that it will release its second-quarter 2026 financial results and provide a business update on Thursday, August 6, 2026. The company is a clinical-stage gene editing firm utilizing its ARCUS® platform to develop in vivo gene editing therapies for various …

Precision BioSciences Inc (DTIL) Institutional Confidence

Precision BioSciences Inc (DTIL) has an institutional shareholding score of 5.00, placing it 132nd in the Biotechnology & Medical Research industry. The institutional shareholding proportion is 60.88%, a significant increase of 64.56% quarter-over-quarter. James Simons is the largest institutional shareholder, though his holding percentage …

Precigen Inc (PGEN) Institutional Confidence

Precigen Inc's institutional confidence score is 7.00, ranking 50th out of 155 in the Pharmaceuticals industry. The latest institutional shareholding proportion increased by 12.24% quarter-over-quarter, reaching 75.82%. Steven Cohen is the largest institutional shareholder, holding 5.84 million shares, representing 1.87% of shares outstanding.

Real Estate Credit Investments Reports £280.7m Portfolio And 138.2p NAV For July 2026

Clinical-stage gene-editing company Precision BioSciences sets Aug. 6 update

Wheaton Precious Metals Aktie: Edison senkt EPS-Prognose

Precision BioSciences Inc (DTIL) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Precision BioSciences Inc (DTIL), highlighting its current risk score of 2.44 within the Biotechnology & Medical Research industry and a beta of 1.31 against the S&P 500. It details various volatility metrics, including maximum drawdown, daily returns, …

PGEN|Precigen Inc|Price:5.950|Chg%:+0.500

TradingKey provides a comprehensive stock analysis of Precigen Inc (PGEN), highlighting its stable fundamentals, high growth potential, and fair valuation. The company's revenue has grown significantly, and it boasts high institutional ownership, with multiple analysts rating it a "Buy." Despite some technical indicators suggesting …

Precipio Inc (PRPO) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Precipio Inc (PRPO), detailing its current risk score of 2.96 within the Healthcare Equipment & Supplies industry. It highlights the company's beta value of 1.33, indicating higher volatility compared to the S&P 500. The assessment also covers …

Earnings Preview: TFPM to Report Financial Results Post-market on August 05

TFPM is scheduled to report its financial results after the market closes on August 05. Investors will be anticipating this announcement to assess the company's performance.

Precision BioSciences Inc (DTIL) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Precision BioSciences Inc (DTIL), focusing on its stock score, support and resistance levels, and various technical indicators and moving averages. The stock is currently trading between a resistance level of 8.85 and a support level of 5.93, …

Praxis Precision Medicines Inc (PRAX) Financial Health: Profitability & Balance Sheet Analysis

This article analyzes the financial health of Praxis Precision Medicines Inc (PRAX), which currently holds a financial score of 6.42, ranking 245 out of 384 in the Biotechnology & Medical Research industry. The company's financial status is stable with low operating efficiency. Key financial …

Precision Optics Corporation Inc (POCI) Institutional Confidence

This article from TradingKey provides an overview of Precision Optics Corporation Inc (POCI)'s institutional confidence, detailing the score and recent changes. It lists major institutional shareholders and their shareholdings, along with percentage changes in their positions. The data is current as of July 30, …

Precision BioSciences (NASDAQ: DTIL) names new COO, CFO and accounting head

Precision BioSciences (NASDAQ: DTIL) has announced a significant restructuring of its senior leadership team, effective August 1, 2026. Alex Kelly has been promoted to Chief Operating Officer, while Naresh Tanna is the new Chief Financial Officer, and Mei Burris will assume responsibilities as Chief …

Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Praxis Precision Medicines, Inc. announced it will release its second-quarter financial results for the period ended June 30, 2026, and provide a corporate update on Thursday, August 6, 2026, before market open. The company will host a conference call and live webcast at 8:30 …

Praxis will webcast its second-quarter update Aug. 6 at 8:30 a.m.

Praxis Precision Medicines (NASDAQ: PRAX) announced it will report its Q2 2026 financial results and provide a corporate update on Thursday, August 6, 2026, before markets open. The company will host a conference call and live webcast at 8:30 a.m. ET on the same …

Earnings Preview: Precigen to Report Financial Results Post-market on August 04

This article announces that Precigen (PGEN) is scheduled to report its financial results after market close on August 4, 2026. The report will cover the company's performance and is an anticipated event for investors and analysts following the company.

Precision Drilling (TSX:PD) Navigates Margin Pressure Amid Growth

Precision BioSciences (DTIL) Expected to Release Quarterly Earnings on Thursday

Wheaton Precious Metals Corp. (WPM) Earnings Expected to Grow: Should You Buy?

Precision Drilling (TSX:PD) Stock Trails Revenue Growth As Margins Crack

Wheaton Precious Metals Corp. $WPM Shares Purchased by Amundi

Precision Drilling Posts Higher Q2 2026 Revenue but Swings to Loss as Investment and International Mix Weigh

Precision Drilling Posts Q2 2026 Revenue Growth Amid Margin Pressure and Expanding Rig Activity

Precision Drilling Q2 Earnings Call Highlights

TD Issues Pessimistic Forecast for Precision Drilling (TSE:PD) Stock Price

Precision Drilling (TSE:PD) Share Price Passes Below 200-Day Moving Average - Here's What Happened

Triple Flag Precious Metals Corp (TFPM) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Triple Flag Precious Metals Corp (TFPM), detailing its current price momentum score, support and resistance levels. It also presents an analysis of various technical indicators (MACD, RSI, KDJ, etc.) and moving averages, offering buy, sell, and neutral …

Precision Drilling Corp (PDS) Valuation: PE, PB & Fair Value Analysis

This article analyzes the valuation of Precision Drilling Corp (PDS), noting its current valuation score of 9.35, placing it 11th out of 88 in its industry. It highlights the company's P/E ratio of -101.89, which is significantly below its recent high and above its …

Precision BioSciences Inc (DTIL) Financial Health: Profitability & Balance Sheet Analysis

The article analyzes the financial health of Precision BioSciences Inc (DTIL), highlighting its strong financial score of 8.85, ranking 23rd in its industry. The company shows robust financial status and high operating efficiency, with a significant year-over-year revenue increase of 37272.41% and a net …

Triple Flag Precious Metals Corp. Revenue Breakdown – MUN:3Y0

Triple Flag Precious Metals Corp. (MUN:3Y0) generated 330.95 million EUR in revenue last year. The Gold segment was the top performer, contributing 142.20 million EUR, while Australia was the greatest regional contributor with 126.51 million EUR. This article provides a breakdown of the company's …

Praxis Precision Medicines Inc (PRAX) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Praxis Precision Medicines Inc (PRAX), noting its current risk score of 2.04, which ranks it 242 out of 384 in the Biotechnology & Medical Research industry. The company's beta value of 2.75 indicates higher volatility compared to …